Add news
March 2010
April 2010
May 2010June 2010July 2010
August 2010
September 2010October 2010
November 2010
December 2010
January 2011
February 2011March 2011April 2011May 2011June 2011July 2011August 2011September 2011October 2011November 2011December 2011January 2012February 2012March 2012April 2012May 2012June 2012July 2012August 2012September 2012October 2012November 2012December 2012January 2013February 2013March 2013April 2013May 2013June 2013July 2013August 2013September 2013October 2013November 2013December 2013January 2014February 2014March 2014April 2014May 2014June 2014July 2014August 2014September 2014October 2014November 2014December 2014January 2015February 2015March 2015April 2015May 2015June 2015July 2015August 2015September 2015October 2015November 2015December 2015January 2016February 2016March 2016April 2016May 2016June 2016July 2016August 2016September 2016October 2016November 2016December 2016January 2017February 2017March 2017April 2017May 2017June 2017July 2017August 2017September 2017October 2017November 2017December 2017January 2018February 2018March 2018April 2018May 2018June 2018July 2018August 2018September 2018October 2018November 2018December 2018January 2019February 2019March 2019April 2019May 2019June 2019July 2019August 2019September 2019October 2019November 2019December 2019January 2020February 2020March 2020April 2020May 2020June 2020July 2020
1234567891011121314
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
News Every Day |

Japan has curbed the spread of the coronavirus so well within the country that it is facing a shortage of patients for clinical trials

Japan has curbed the spread of the coronavirus so well within the country that it is facing a shortage of patients for clinical trials

Tokyo Japan coronavirusCarl Court/Getty Images

  • Japan was successful in containing the spread of the coronavirus within the country, so much so that it is now facing a shortage of patients to enroll in clinical trials.
  • While the epidemic drove Japan's medical system to the brink of collapse in recent months, serious cases now number about 60 nationwide.
  • "Due to the decreasing number of coronavirus infections, we believe it will take some time before clinical research is completed," said Tetsuya Nakamura, who is running a trial of Avigan at Gunma University Hospital in central Japan.
  • With a dearth of domestic patients, Japan may have to rely more on overseas data and results to aid in regulatory approvals.
  • Visit Business Insider's homepage for more stories.

TOKYO (Reuters) - As nations race to develop treatments and vaccines for COVID-19, Japan has become a victim of its own success as slowing new infections has led to a shortage of patients to enroll in clinical trials.

Clinical trials are underway for more than a dozen potential vaccines, including at least six in China, but Japan's first human trials are expected to start next month.

See the rest of the story at Business Insider

NOW WATCH: How the Navy's largest hospital ship can help with the coronavirus

See Also:



Read also

Arsenal ace Mavropanos wanted by Werder Bremen on season-long loan transfer with 22-year-old not in Arteta’s plans

Government ‘set to allow fans back into Premier League games from September’… but will face masks have to be worn?

Journalist: Chelsea FC preparing their first offer to sign Kai Havertz



News, articles, comments, with a minute-by-minute update, now on Today24.pro




Today24.pro — latest news 24/7. You can add your news instantly now — here